Category: Intellectual property
-
Biotech, Univ of Miami Spin-Off Vaccine Company
Biotechnology company Heat Biologics Inc. is licensing research from University of Miami in Florida to develop vaccines against infectious diseases, starting with the Zika virus, in a new subsidiary.
-
Vaccine Stops Livestock Infections Without Antibiotics
A veterinary medical team at Kansas State University developed a vaccine that protects livestock against dangerous liver and skin infections without antibiotics.
-
Gene Silencing Treatments Licensed for Heart Disease
Biopharmaceutical company Amgen is acquiring the rights to a technology that stops the actions of inherited genes associated with a leading type of heart disease.
-
Harvard Spin-Off to Sequence, Visualize RNA in Tissue
A new spin-off enterprise from Harvard University is commercializing technology that enables sequencing and imaging of genetic transcriptions of cells in their original tissue.
-
Spin-Off Companies to Develop Chronic Disease Therapies
Two new spin-off enterprises are being created to develop gut-based treatments for chronic diseases using technologies from synthetic biology company Intrexon Corporation.
-
Monsanto Licensing MIT/Harvard Genome Editing
Monsanto Company is licensing genomic editing technology for agricultural applications from a joint research center at Harvard University and MIT.
-
Genentech, BioNTech Partner on Personal Cancer Therapies
Biotechnology company BioNTech AG is licensing its messenger RNA technology and collaborating with biopharmaceutical company Genentech to develop personalized cancer immunotherapies.
-
Teva Licenses Pain Relief Antibody for $1.25 Billion
Teva Pharmaceutical Industries is licensing from biotechnology company Regeneron Pharmaceuticals an engineered antibody that targets proteins supporting pain signals.
-
Patent Issued for Online Hearing Aid Calibration
A technology for fitting and programming a hearing aid online received a U.S. patent earlier this month, awarded to iHear Medical Inc.
-
Synthetic Viruses in Gene Therapy Licensed for Production
Techniques from academic research for developing synthetic viruses to deliver gene therapies are being licensed for commercial production and distribution.